7,954
Views
101
CrossRef citations to date
0
Altmetric
Original Articles

Harm reduction as paradigm: Is better than bad good enough? The origins of harm reduction

Pages 243-250 | Published online: 20 Aug 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (14)

Jason V. D’Amours. (2022) Cultural discourses and HIV/AIDS activists’ meanings about PrEP. Culture, Health & Sexuality 0:0, pages 1-15.
Read now
Meg Stalcup & Yvonne Wallace. (2021) Careful Practices: Ethics and the Anethical in Canadian Addiction Trajectories. Medical Anthropology 40:5, pages 417-431.
Read now
Suzanne Fraser, kylie valentine & Kate Seear. (2018) Emergent publics of alcohol and other drug policymaking. Critical Policy Studies 12:1, pages 61-81.
Read now
Jeannette Pols, Brigitte Althoff & Els Bransen. (2017) The Limits of Autonomy: Ideals in Care for People with Learning Disabilities. Medical Anthropology 36:8, pages 772-785.
Read now
Margaret Pereira & John Scott. (2017) Harm reduction and the ethics of drug use: contemporary techniques of self-governance. Health Sociology Review 26:1, pages 69-83.
Read now
Katherine McLean. (2015) From responsible users to recalcitrant dope fiends: Mapping modes of engagement with harm reduction. Addiction Research & Theory 23:6, pages 490-498.
Read now
Kirsten Bell & Judith Green. (2015) Keeping a critical edge: reflections on 25 years as a scholarly journal. Critical Public Health 25:1, pages 1-3.
Read now
Christopher B.R. Smith. (2012) Harm reduction as anarchist practice: a user's guide to capitalism and addiction in North America. Critical Public Health 22:2, pages 209-221.
Read now
Katherine McLean. (2011) The biopolitics of needle exchange in the United States. Critical Public Health 21:1, pages 71-79.
Read now
Lois Jackson, Joanne Parker, Margaret Dykeman, Jacqueline Gahagan & Jeff Karabanow. (2010) The power of relationships: Implications for safer and unsafe practices among injection drug users. Drugs: Education, Prevention and Policy 17:3, pages 189-204.
Read now
Jo Morrison. Anti-Doping Policy, Health, and Harm. Sport, Ethics and Philosophy 0:0, pages 1-14.
Read now
Celeste Macevicius, Daniel Gudiño Pérez, Alexa Norton, Gillian Kolla, Phoenix Beck-McGreevy, Marion Selfridge, Jeremy Kalicum, Abby Hutchison, Karen Urbanoski, Brittany Barker, Amanda Slaunwhite, Bohdan Nosyk & Bernadette (Bernie) Pauly. Just have this come from their prescription pad: the medicalization of safer supply from the perspectives of health planners in BC, Canada. Drugs: Education, Prevention and Policy 0:0, pages 1-11.
Read now

Articles from other publishers (87)

Melissa Ceuterick, Pauline Van Ngoc, Piet Bracke & Beatrice Scholtes. (2023) From prescribing dilemma to knowledge in practice: The ontological politics of benzodiazepines and Z-drugs. Social Science & Medicine 339, pages 116358.
Crossref
Nicholas Kontos & Vinod Rao. (2023) Clinical harm reduction in substance use: An ethics‐oriented primer and critique for hospital‐based providers. Journal of Evaluation in Clinical Practice.
Crossref
Kenji Logie, Katheryne Pugliese & Alexis Acevedo. (2023) An examination of harm reduction strategies in Oxycodone and Adderall buyer feedback on AlphaBay. Criminology & Public Policy 22:4, pages 695-733.
Crossref
Jeremy Levenson, Lauren Textor, Ricky Bluthenthal, Anna Darby, Rafik Wahbi & Mark-Anthony Clayton-Johnson. (2023) Abolition and harm reduction in the struggle for “Care, Not Cages”. International Journal of Drug Policy 121, pages 104163.
Crossref
Torkel Richert, Anke Stallwitz & Johan Nordgren. (2023) Harm reduction social work with people who use drugs: a qualitative interview study with social workers in harm reduction services in Sweden. Harm Reduction Journal 20:1.
Crossref
Jordan A. Killion, Christopher Magana, Javier A. Cepeda, Anh Vo, Maricris Hernandez, Cassandra L. Cyr, Karen M. Heskett, David P. Wilson, Joshua Graff Zivin, María L. Zúñiga, Heather A. Pines, Richard S. Garfein, Peter Vickerman, Fern Terris-PrestholtAdriane Wynn & Natasha K. Martin. (2023) Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation. AIDS.
Crossref
Sunny Jiao, Vicky Bungay, Emily Jenkins & Marilou Gagnon. (2023) How an emergency department is organized to provide opioid-specific harm reduction and facilitators and barriers to harm reduction implementation: a systems perspective. Harm Reduction Journal 20:1.
Crossref
Sarah A. White, Rachel Lee, Alene Kennedy-Hendricks, Susan G. Sherman & Emma E. McGinty. (2023) Perspectives of U.S. harm reduction advocates on persuasive message strategies. Harm Reduction Journal 20:1.
Crossref
Hélène Poliquin, Michel Perreault, Ana C. Villela Guilhon & Karine Bertrand. (2022) Improving Harm Reduction Services: A Qualitative Study on the Perspectives of Highly Marginalized Persons Who Inject Drugs in Montreal. Journal of Drug Issues 53:3, pages 375-401.
Crossref
Jasper Bongers. (2023) Harm Reduction as a Citizenship Movement: The Case of Hoog Catharijne, Utrecht (1973–2001). The Social History of Alcohol and Drugs 37:1, pages 4-34.
Crossref
Ken YatesKen Yates. 2023. What Do Needle and Syringe Programs Do?. What Do Needle and Syringe Programs Do? 145 168 .
Ken YatesKen Yates. 2023. What Do Needle and Syringe Programs Do?. What Do Needle and Syringe Programs Do? 1 43 .
Joana Canêdo, Kali-olt Sedgemore, Kelly Ebbert, Haleigh Anderson, Rainbow Dykeman, Katey Kincaid, Claudia Dias, Diana Silva, Reith Charlesworth, Rod Knight & Danya Fast. (2022) Harm reduction calls to action from young people who use drugs on the streets of Vancouver and Lisbon. Harm Reduction Journal 19:1.
Crossref
Katherine Rudzinski, Soo Chan Carusone, Andre Ceranto, Francisco Ibáñez-Carrasco, Lisa McDonald, Dean Valentine, Adrian Guta, Elaine Hyshka, William O’Leary, Andra Cardow & Carol Strike. (2022) Philanthropic donor perspectives about providing harm reduction services for people living with HIV/AIDS in a hospital setting. Harm Reduction Journal 19:1.
Crossref
Andrew Lustig & Gavin Brookes. (2022) Construction of group norms in a radical acceptance online forum for heavy alcohol users: A corpus-based discourse analysis. International Journal of Drug Policy 109, pages 103862.
Crossref
Anthony DiMario. (2022) To Punish, Parent, or Palliate: Governing Urban Poverty through Institutional Failure. American Sociological Review 87:5, pages 860-888.
Crossref
SE Schroeder, A Bourne, JS Doyle, ME Hellard, M Stoové & A Pedrana. (2022) Constructing a ‘target population’: A critical analysis of public health discourse on substance use among gay and bisexual men, 2000–2020. International Journal of Drug Policy 108, pages 103808.
Crossref
Nicole D. Gehring, Kelsey A. Speed, T. Cameron Wild, Bernie Pauly, Ginetta Salvalaggio & Elaine Hyshka. (2022) Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study. International Journal of Drug Policy 108, pages 103805.
Crossref
Parnika Godkhindi, Lisa Nussey & Tim O’Shea. (2022) “They're causing more harm than good”: a qualitative study exploring racism in harm reduction through the experiences of racialized people who use drugs. Harm Reduction Journal 19:1.
Crossref
Katrina Milaney, Rebecca Haines-Saah, Brenlea Farkas, Oluwaseun Egunsola, Liza Mastikhina, Sage Brown, Diane Lorenzetti, Brian Hansen, Kerry McBrien, Katherine Rittenbach, Leslie Hill, Claire O'Gorman, Christopher Doig, Jason Cabaj, Caitlin Stokvis & Fiona Clement. (2022) A scoping review of opioid harm reduction interventions for equity-deserving populations. The Lancet Regional Health - Americas 12, pages 100271.
Crossref
Dina Perrone, Aili Malm & Erica Jovanna Magaña. (2021) Harm Reduction Policing: An Evaluation of Law Enforcement Assisted Diversion (LEAD) in San Francisco. Police Quarterly 25:1, pages 7-32.
Crossref
Philip R Kavanaugh. (2020) Narcan as biomedical panic: The war on overdose and the harms of harm reduction. Theoretical Criminology 26:1, pages 132-152.
Crossref
Ximene RÊGO, Maria João OLIVEIRA, Catarina LAMEIRA & Olga S. CRUZ. (2021) 20 years of Portuguese drug policy - developments, challenges and the quest for human rights. Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref
A. Greer, J. A. Buxton, B. Pauly & V. Bungay. (2021) Organizational support for frontline harm reduction and systems navigation work among workers with living and lived experience: qualitative findings from British Columbia, Canada. Harm Reduction Journal 18:1.
Crossref
Deborah O'Connor. (2020) Mothering through a child's addiction journey: Linking lived experience to the lenses that shape intervention. Journal of Social Work 21:6, pages 1339-1359.
Crossref
David Showalter, Lynn D. Wenger, Barrot H. Lambdin, Eliza Wheeler, Ingrid Binswanger & Alex H. Kral. (2021) Bridging institutional logics: Implementing naloxone distribution for people exiting jail in three California counties. Social Science & Medicine 285, pages 114293.
Crossref
Lynn D. Wenger, Alex H. Kral, Ricky N. Bluthenthal, Terry Morris, Lee Ongais & Barrot H. Lambdin. (2021) Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises. Translational Research 234, pages 159-173.
Crossref
Jarrett Zigon. (2021) How is it between us? Relational ethics and transcendence. Journal of the Royal Anthropological Institute 27:2, pages 384-401.
Crossref
April Henning, Katherine McLean, Jesper Andreasson & Paul Dimeo. (2021) Risk and enabling environments in sport: Systematic doping as harm reduction. International Journal of Drug Policy 91, pages 102897.
Crossref
Michelle C. Danda. (2021) The Missing Link. Journal of Addictions Nursing 32:2, pages 121-125.
Crossref
Niklas Karlsson, Torsten Berglund, Anna Mia Ekström, Anders Hammarberg & Tuukka Tammi. (2020) Could 30 years of political controversy on needle exchange programmes in Sweden contribute to scaling-up harm reduction services in the world?. Nordic Studies on Alcohol and Drugs 38:1, pages 66-88.
Crossref
Nicholas B. King. (2020) Harm Reduction: A Misnomer. Health Care Analysis 28:4, pages 324-334.
Crossref
Janet Jones. (2020) What Do We Mean When We Call Someone a Drug Addict?. Health Care Analysis 28:4, pages 391-403.
Crossref
Daniel M. Weinstock. (2020) Disagreement, Unenforceability, and Harm Reduction. Health Care Analysis 28:4, pages 314-323.
Crossref
Alana Klein. (2020) Harm Reduction Works: Evidence and Inclusion in Drug Policy and Advocacy. Health Care Analysis 28:4, pages 404-414.
Crossref
Liam Kennedy & Madelaine Coelho. (2019) “Absolutely the worst drug I’ve ever seen”: Risk, governance, and the construction of the illicit fentanyl “crisis”. Theoretical Criminology 24:4, pages 612-632.
Crossref
Mark Jayne & Andrew Williams. (2020) Faith-based alcohol treatment in England and Wales: New evidence for policy and practice. Health & Place 66, pages 102457.
Crossref
Sylvia McKelvie. (2020) “Smack in the Middle”: Urban Governance and the Spatialization of Overdose Epidemics. City & Community 19:3, pages 704-725.
Crossref
Magnus Nowell & Jeffrey R. Masuda. (2020) “You need to just provide health services:” navigating the politics of harm reduction in the twin housing and overdose crises in Vancouver, BC. International Journal of Drug Policy 82, pages 102774.
Crossref
Margaret Pereira, John Scott & Amanda Beem. (2020) Imaginary Drug Control and the Failures of Contemporary Australian Drug Policy. Contemporary Drug Problems 47:1, pages 29-42.
Crossref
Geoff J. Bathje, Daniel Pillersdorf, Laura Kacere & Dan Bigg. (2019) Helping behaviour among people who use drugs: Altruism and mutual aid in a harm reduction program. Journal of Community & Applied Social Psychology 30:2, pages 119-131.
Crossref
Tara Marie Watson, Gillian Kolla, Emily van der Meulen & Zoë Dodd. (2020) Critical studies of harm reduction: Overdose response in uncertain political times. International Journal of Drug Policy 76, pages 102615.
Crossref
Alissa Greer & Alison Ritter. (2020) The legal regulation of drugs and role of government: Perspectives from people who use drugs. Drug and Alcohol Dependence 206, pages 107737.
Crossref
Adrian Barton. 2020. Cultures of Intoxication. Cultures of Intoxication 311 333 .
Carla Regina Moreira, Cassia Baldini Soares, Celia Maria Sivalli Campos & Thais Helena Mourão Laranjo. (2019) Harm reduction: trends being disputed in health policies. Revista Brasileira de Enfermagem 72:suppl 3, pages 312-320.
Crossref
Tobias Kammersgaard. (2019) Harm Reduction Policing: From Drug Law Enforcement to Protection. Contemporary Drug Problems 46:4, pages 345-362.
Crossref
Stephanie Campos, Ellen Benoit & Eloise Dunlap. (2019) Risk management strategies of synthetic cannabis users. Drugs and Alcohol Today 19:4, pages 270-281.
Crossref
Kwanwook Kim. (2019) Finding the Boundary of Harm: Anthropological Approach to ‘Scientific debate’ on Electronic Cigarettes (Liquid/Cigarette Type) and Smoking Cessation. Journal of the Korean Society for Research on Nicotine and Tobacco 10:1, pages 9-12.
Crossref
Leela Steiner, Anne-Marie Nicol & Angela Eykelbosh. (2019) How we talk about “Pot” matters: strategies for improved cannabis risk communication. Environmental Health Review 62:1, pages 8-13.
Crossref
Jesse Proudfoot. (2017) The libidinal economy of revanchism: Illicit drugs, harm reduction, and the problem of enjoyment. Progress in Human Geography 43:2, pages 214-234.
Crossref
Heitor Martins Pasquim, Sheila Aparecida Ferreira Lachtim & Cassia Baldini Soares. (2019) Conteúdo sobre drogas em jogos para dispositivos móveis. Revista da Escola de Enfermagem da USP 53.
Crossref
Aline Godoy-Vieira, Cassia Baldini Soares, Luciana Cordeiro & Célia Maria Sivalli Campos. (2018) Inclusive and emancipatory approaches to occupational therapy practice in substance-use contexts. Canadian Journal of Occupational Therapy 85:4, pages 307-317.
Crossref
Danya Fast & David Cunningham. (2018) “We Don’t Belong There”: New Geographies of Homelessness, Addiction, and Social Control in Vancouver’s Inner City. City & Society 30:2, pages 237-262.
Crossref
Daniel Z Buchman, Aaron M Orkin, Carol Strike & Ross E G Upshur. (2018) Overdose Education and Naloxone Distribution Programmes and the Ethics of Task Shifting. Public Health Ethics 11:2, pages 151-164.
Crossref
Giulia Federica Zampini. (2018) Evidence and morality in harm-reduction debates: can we use value-neutral arguments to achieve value-driven goals?. Palgrave Communications 4:1.
Crossref
Ellen Sofie Andvig, Knut Tore Sælør & Esther Ogundipe. (2018) Harm reduction in a Norwegian housing first project: a qualitative study of the treatment providers’ practice. Advances in Dual Diagnosis 11:1, pages 4-15.
Crossref
Nancy Tamimi. 2018. Philosophies and Sociologies of Bioethics. Philosophies and Sociologies of Bioethics 127 147 .
Caroline ChatwinCaroline Chatwin. 2018. Towards More Effective Global Drug Policies. Towards More Effective Global Drug Policies 53 89 .
L. M. Boucher, Z. Marshall, A. Martin, K. Larose-Hébert, J. V. Flynn, C. Lalonde, D. Pineau, J. Bigelow, T. Rose, R. Chase, R. Boyd, M. Tyndall & C. Kendall. (2017) Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs. Harm Reduction Journal 14:1.
Crossref
Nikki Bozinoff, Will Small, Cathy Long, Kora DeBeck & Danya Fast. (2017) Still “at risk”: An examination of how street-involved young people understand, experience, and engage with “harm reduction” in Vancouver’s inner city. International Journal of Drug Policy 45, pages 33-39.
Crossref
Aziza Ahmed. 2017. Revisiting the Law and Governance of Trafficking, Forced Labor and Modern Slavery. Revisiting the Law and Governance of Trafficking, Forced Labor and Modern Slavery 305 328 .
Rachel Faulkner-Gurstein. (2017) The social logic of naloxone: Peer administration, harm reduction, and the transformation of social policy. Social Science & Medicine 180, pages 20-27.
Crossref
Dessa Bergen-Cico, Ketavan Sikharulidze, Nato Ivanashvili, Mikheil Ivanishvili & Tamar Keshelava. (2017) Hepatitis C Risk and Protective Factors Associated With Drug Policies in the Republic of Georgia. World Medical & Health Policy 9:1, pages 45-64.
Crossref
Daniel Z. Buchman, Pamela Leece & Aaron Orkin. (2021) The Epidemic as Stigma: The Bioethics of Opioids. Journal of Law, Medicine & Ethics 45:4, pages 607-620.
Crossref
Seán FoySeán Foy. 2017. Solution Focused Harm Reduction. Solution Focused Harm Reduction 33 52 .
Mads Peter Karlsen & Kaspar Villadsen. (2016) Health Promotion, Governmentality and the Challenges of Theorizing Pleasure and Desire. Body & Society 22:3, pages 3-30.
Crossref
Suzanne Fraser. (2016) Articulating addiction in alcohol and other drug policy: A multiverse of habits. International Journal of Drug Policy 31, pages 6-14.
Crossref
Dessa Bergen-Cico & Alicia Lapple. (2015) Examination of Safe Crack Use Kit Distribution from a Public Health Perspective. World Medical & Health Policy 7:4, pages 349-367.
Crossref
Margaret Kathleen Dechman. (2015) Peer helpers’ struggles to care for “others” who inject drugs. International Journal of Drug Policy 26:5, pages 492-500.
Crossref
Stian Biong & Anna-Sabina Soggiu. (2015) «Her tar de tingene i henda og gjør noe med det» - Om recovery-orienteringen i en kommunal ROP-tjeneste. Tidsskrift for psykisk helsearbeid 12:1, pages 51-60.
Crossref
Eugene McCann & Cristina Temenos. (2015) Mobilizing drug consumption rooms: inter-place networks and harm reduction drug policy. Health & Place 31, pages 216-223.
Crossref
Julie Ham & Alison Gerard. (2013) Strategic in/visibility: Does agency make sex workers invisible?. Criminology & Criminal Justice 14:3, pages 298-313.
Crossref
Marie Claire Van Hout & Tim Bingham. (2013) A Qualitative Study of Prescribing Doctor Experiences of Methadone Maintenance Treatment. International Journal of Mental Health and Addiction 12:3, pages 227-242.
Crossref
Denielle Elliott. (2014) Debating Safe Injecting Sites in Vancouver's Inner City: Advocacy, Conservatism and Neoliberalism. Contemporary Drug Problems 41:1, pages 5-40.
Crossref
Katherine McLean. (2013) Reducing Risk, Producing Order: The Surprisingly Disciplinary World of Needle Exchange. Contemporary Drug Problems 40:3, pages 415-445.
Crossref
Max Hopwood & Carla Treloar. 2013. Interventions for Addiction. Interventions for Addiction 735 743 .
Joanna N. Erdman. (2012) Harm reduction, human rights, and access to information on safer abortion. International Journal of Gynecology & Obstetrics 118:1, pages 83-86.
Crossref
Katherine McLean. (2012) Needle exchange and the geography of survival in the South Bronx. International Journal of Drug Policy 23:4, pages 295-302.
Crossref
Teresa Gowan, Sarah Whetstone & Tanja Andic. (2012) Addiction, agency, and the politics of self-control: Doing harm reduction in a heroin users’ group. Social Science & Medicine 74:8, pages 1251-1260.
Crossref
David R. Bewley-Taylor. 2012. International Drug Control. International Drug Control 36 99 .
Linn Gjersing, Helge Waal, John RM Caplehorn, Michael Gossop & Thomas Clausen. (2010) Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment. BMC Health Services Research 10:1.
Crossref
Mark Peyrot & Stacy Lee Burns. 2010. New Approaches to Social Problems Treatment. New Approaches to Social Problems Treatment 287 298 .
Jill Owczarzak. (2009) Defining HIV Risk and Determining Responsibility in Postsocialist Poland. Medical Anthropology Quarterly 23:4, pages 417-435.
Crossref
Gary W Dowsett. (2009) Dangerous desires and post-queer HIV prevention: Rethinking community, incitement and intervention. Social Theory & Health 7:3, pages 218-240.
Crossref
Kevin Walby. (2014) Hunting for Harm: Risk-Knowledge Networks, Local Governance, and the Ottawa Needle Hunter Program.. Canadian journal of law and society 23:1-2, pages 161-178.
Crossref
Ditte Andersen & Margaretha Järvinen. (2017) Harm Reduction – Ideals and Paradoxes. Nordic Studies on Alcohol and Drugs 24:3, pages 235-252.
Crossref
Ditte Andersen & Margaretha Järvinen. (2017) Harm reduction – ideals and paradoxes. Nordic Studies on Alcohol and Drugs 23:5, pages 305-321.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.